We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

QIAGEN Signs Ninth Master Collaboration Agreement for Companion Diagnostics

News   Nov 13, 2014

 
QIAGEN Signs Ninth Master Collaboration Agreement for Companion Diagnostics
 
 
 

RELATED ARTICLES

Post-heart Attack Antibody Levels May Guide Treatment

News

Levels of antiphospholipid antibodies, which are associated with rheumatic diseases, are also elevated in myocardial infarction without any autoimmune co-morbidity.

READ MORE

Drug Combo Destroys Chemo-resistant Blood Cancer

News

Researchers have developed a promising targeted strategy to treat chemotherapy-resistant acute myeloid leukemia (AML) and a diagnostic test to determine which AML patients would most likely benefit from this treatment.

READ MORE

Test Which Identifies Drug-resistant Tuberculosis Bacteria Now Available In Europe

News

Now available in Europe: A diagnostic test which can simultaneously detect tuberculosis-causing bacteria and determine if the bacteria contain mutations associated with resistance to two important first line drugs.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Genomics Research Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE